A Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)

Trial Profile

A Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)

Completed
Phase of Trial: Phase II/III

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Neridronic acid (Primary)
  • Indications Complex regional pain syndromes
  • Focus Therapeutic Use
  • Sponsors Grunenthal
  • Most Recent Events

    • 16 Dec 2016 According to a Grunenthal media release, data from this study supported breakthrough therapy designation for Neridronic Acid.
    • 11 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 05 Sep 2016 Planned End Date changed from 1 Jan 2017 to 1 Nov 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top